Tonight maybe the last opportunity to make a calm statement before all hell breaks loose when the market opens tomorrow morning. I believe we have exquisite science and a great product moving forward in clinical trial for Hep C, as well as a super antiviral platform in general. I am confident that the results will reflect this science and also be exquisite. The best of luck to all longs including some of my not so good friends. This week brings to validation over 20 years of research and development. Enjoy the ride to the North Pole. ..................ruby
For all invested in AVII, and all infected with HCV and all other virus, and as a tribute to man's undying desire to understand and help his brothers, let us raise our glasses to AVI Biopharma, Virus Killer!